Celularity Inc. (CELU) vs Werewolf Therapeutics, Inc. (HOWL)
A side-by-side comparison of Celularity Inc. and Werewolf Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.60HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
HOWL
Werewolf Therapeutics, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — CELU vs HOWL
growth of $100 · dividends reinvested · last 5yCELU -98.3% (-55.8%/yr)HOWL -94.2% (-43.5%/yr)HOWL compounded faster over this window
CELU HOWL
CELU vs HOWL: by the numbers
- •CELU is the larger company ($46M vs $45M market cap).
- •Both run net losses; HOWL's is the smaller (-164.82% vs -375.77% net margin).
Metrics side by side
Valuation
| Metric | CELU | HOWL |
|---|---|---|
| P/S ratio | 2.44 | 2.14 |
| P/B ratio | N/A | 2.76 |
Profitability
| Metric | CELU | HOWL |
|---|---|---|
| Gross margin | 79.62% | 0.00% |
| Operating margin | -230.92% | 0.00% |
| Net margin | -375.77% | -164.82% |
| ROE | N/A | -212.45% |
| ROIC | -192.99% | -156.97% |
Growth (annualized)
| Metric | CELU | HOWL |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -44.27% |
Frequently asked
- How have CELU and HOWL total returns compared?
- Over the past 5 years, CELU delivered -52.57% and HOWL delivered -44.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.